BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31948376)

  • 1. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Evaluation of the TIGRIS Vascular Stent Within a Modern Treatment Algorithm.
    Werner M; Gomari-Grisar F; Belalcazar S; Hirschl M; Kalchhauser G; Al-Taiee B; Jäger N; Westhausser C; Tischler M; Tischler R
    J Endovasc Ther; 2019 Oct; 26(5):637-642. PubMed ID: 31303096
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
    Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
    J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictability and usefulness of intravascular ultrasound-guided angioplasty in patients with femoropopliteal lesions.
    Jiang J; Xu W
    Int Angiol; 2022 Feb; 41(1):74-81. PubMed ID: 34825800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
    Aihara H; Higashitani M; Takimura H; Tobita K; Jujo K; Hozawa K; Yamaguchi T; Iwata Y; Tokuyama H; Sakurai M; Murata N; Fujimoto Y; Kikuchi A; Koganei H; Sato A; Noguchi Y; Ieda M
    Circ J; 2020 Jul; 84(8):1320-1329. PubMed ID: 32581151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention.
    Armstrong EJ; Singh S; Singh GD; Yeo KK; Ludder S; Westin G; Anderson D; Dawson DL; Pevec WC; Laird JR
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1168-74. PubMed ID: 23630047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation.
    Nakazawa KR; Wengerter SP; Power JR; Lookstein RA; Tadros RO; Ting W; Faries PL; Vouyouka AG
    J Vasc Surg; 2017 Jul; 66(1):151-159. PubMed ID: 28259571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Cilostazol Administration on Femoropopliteal In-Stent Restenosis.
    Tomoi Y; Soga Y; Iida O; Fujihara M; Ando K
    J Endovasc Ther; 2017 Oct; 24(5):640-646. PubMed ID: 28675951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumen Gain After Endovascular Therapy in Calcified Superficial Femoral Artery Occlusive Disease Assessed by Intravascular Ultrasound (CODE Study).
    Fujihara M; Kozuki A; Tsubakimoto Y; Takahara M; Shintani Y; Fukunaga M; Iwasaki Y; Nakama T; Yokoi Y
    J Endovasc Ther; 2019 Jun; 26(3):322-330. PubMed ID: 30873909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of heparin-bonded covered stent and bare-nitinol stent assessed by intravascular ultrasound.
    Katsuki T; Tomoi Y; Yamaji K; Soga Y; Imada K; Ito N; Hiramori S; Ando K
    Heart Vessels; 2020 Nov; 35(11):1502-1509. PubMed ID: 32462463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.